Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zidovudine.

W G Powderly

    Missouri Medicine
    |November 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Zidovudine (AZT) is a key HIV treatment, but its use can cause serious side effects. This article highlights managing AZT therapy and its associated adverse events.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rifabutin induced vitritis in AIDS patients.

    Ocular immunology and inflammation·2012
    Same author

    Progenitor cell types in HIV-1 infection: bioactivity and emerging targets for treatment.

    Current HIV research·2009
    Same author

    Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.

    HIV medicine·2009
    Same author

    European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

    HIV medicine·2008
    Same author

    Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?

    HIV medicine·2007
    Same author

    Predictors of immunity after hepatitis A vaccination in HIV-infected persons.

    Journal of viral hepatitis·2007
    Same journal

    Save the Date!: 169th Annual Convention | April 2-4, 2027, InterContinental at the Plaza | Kansas City, Missouri.

    Missouri medicine·2026
    Same journal

    Inequity in Physician Compensation Is Killing Private Practice.

    Missouri medicine·2026
    Same journal

    Sweetness at a Cost: The Story and Science of High-Fructose Corn Syrup.

    Missouri medicine·2026
    Same journal

    The Role of Artificial Intelligence in Acute Ischemic Stroke Care: A Narrative Review.

    Missouri medicine·2026
    Same journal

    Long-Term Cardiac Rhythm Monitoring After Ischemic Stroke: Detecting Atrial Fibrillation in the Era of Atrial Cardiopathy.

    Missouri medicine·2026
    Same journal

    Recipients of the 50-Year Physician Pin.

    Missouri medicine·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Clinical Medicine

    Background:

    • Zidovudine (azidothymidine, AZT) is the sole approved medication for HIV infection.
    • While effective in inhibiting HIV, AZT is linked to significant adverse effects.

    Purpose of the Study:

    • To highlight the management strategies for zidovudine (AZT) therapy.
    • To provide guidance on managing the side effects associated with AZT treatment.

    Main Methods:

    • Review of clinical management protocols for zidovudine therapy.
    • Analysis of reported side effects and their clinical implications.

    Main Results:

    • Zidovudine (AZT) effectively inhibits HIV replication.
    • A range of side effects, some severe, are associated with AZT use.

    Conclusions:

    • Effective management of zidovudine (AZT) therapy is crucial for patients with HIV.
    • Addressing and mitigating AZT's side effects is essential for patient care.